Mirati Therapeutics, Inc. (MRTX) has a market capitalization of $4.12B and trades at $58.70. The 52-week range is 27.3-64.41.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.5, Earnings Per Share (EPS) of $-13.18, annual revenue of $12.44M.
The stock has a beta of 0.77, operates in the Healthcare sector.
